High Rates of Genetic Diagnosis in Psychiatric Patients with and without Neurodevelopmental Disorders: Toward Improved Genetic Diagnosis in Psychiatric Populations
- PMID: 32495635
- PMCID: PMC7658423
- DOI: 10.1177/0706743720931234
High Rates of Genetic Diagnosis in Psychiatric Patients with and without Neurodevelopmental Disorders: Toward Improved Genetic Diagnosis in Psychiatric Populations
Abstract
Objective: There is a paucity of literature on genetic diagnosis in psychiatric populations, particularly the vulnerable population of patients with concomitant neurodevelopmental disorder (NDD). In this cross-sectional study, we investigated the genetic diagnostic rate in 151 adult psychiatric patients from two centers in Ontario, Canada, including a large subset (73.5%) with concurrent NDD, and performed phenotypic analysis to determine the strongest predictors for the presence of a genetic diagnosis.
Method: Patients 16 years of age or older and affected with a psychiatric disorder plus at least one of NDD, neurological disorder, congenital anomaly, dysmorphic features, or family history of NDD were recruited through the genetics clinics between 2012 and 2016. Patients underwent genetic assessment and testing according to clinical standards. Chi-squared test was used for phenotypic comparisons. Multivariate logistic regression analysis was performed to determine which phenotypic features were predictive of genetic diagnosis types.
Results: Overall, 45.7% of patients in the total cohort were diagnosed with genetic disorders with the vast majority of diagnoses (89.9%) comprising single gene and chromosomal disorders. There were management and treatment implications for almost two-thirds (63.8%) of diagnosed patients. Presence of a single gene disorder or chromosomal diagnosis was predicted by differing combinations of neurological, NDD, and psychiatric phenotypes.
Conclusion: The results of this study highlight the frequency and impact of genetic diagnosis in psychiatric populations, particularly those with concomitant NDD. Genetic assessment should be considered in psychiatric patients, particularly those with multiple brain phenotypes (psychiatric, neurodevelopmental, neurological).
Objectif :: Il y a un manque dans la littérature à l’égard du diagnostic génétique dans les populations psychiatriques, particulièrement pour la population vulnérable de patients qui présentent un trouble neurodéveloppemental (TND) concomitant. Dans la présente étude transversale, nous avons recherché le taux des diagnostics génétiques chez 151 patients psychiatriques adultes de deux centres de l’Ontario, Canada, incluant un vaste sous-ensemble (73,5%) souffrant d’un TND concomitant, et nous avons mené une analyse phénotypique pour déterminer les prédicteurs les plus efficaces de la présence d’un diagnostic génétique.
Méthodes :: Les patients de 16 ans ou plus souffrant d’un trouble psychiatrique en plus d’au moins un TND, d’un trouble neurologique, d’une anomalie congénitale, de traits dysmorphiques ou d’antécédents familiaux de TND ont été recrutés dans des cliniques génétiques entre 2012 et 2016. Les patients ont subi une évaluation et un dépistage génétique conformément aux normes cliniques. Un test du chi carré a été utilisé pour les comparaisons phénotypiques. Une analyse de régression logistique multivariée a été menée afin de déterminer quelles caractéristiques phénotypiques prédisaient les types de diagnostic génétique.
Résultats :: Généralement, 45.7% des patients de toute la cohorte avaient reçu un diagnostic de troubles génétiques, et la vaste majorité des diagnostics (89.9%) comprenaient des troubles monogéniques et chromosomiques. Il y avait des implications pour la prise en charge et le traitement chez près des deux tiers (63.8%) des patients diagnostiqués. La présence d’un trouble monogénique ou d’un diagnostic chromosomique était prédite par différentes combinaisons de phénotypes neurologiques, de TND et psychiatriques.
Conclusion :: Les résultats de cette étude montrent la fréquence et l’effet d’un diagnostic génétique dans les populations psychiatriques, particulièrement celles qui souffrent d’un TND concomitant. L’évaluation génétique devrait être prise en considération chez les patients psychiatriques, particulièrement ceux qui présentent de multiples phénotypes du cerveau (psychiatriques, neurodéveloppementaux, neurologiques).
Keywords: adult psychiatry; dual diagnosis; genetics; screening.
Conflict of interest statement
Similar articles
-
Clinical Characterization of Copy Number Variants Associated With Neurodevelopmental Disorders in a Large-scale Multiancestry Biobank.JAMA Psychiatry. 2022 Mar 1;79(3):250-259. doi: 10.1001/jamapsychiatry.2021.4080. JAMA Psychiatry. 2022. PMID: 35080590 Free PMC article.
-
Targeted gene sequencing in 6994 individuals with neurodevelopmental disorder with epilepsy.Genet Med. 2019 Nov;21(11):2496-2503. doi: 10.1038/s41436-019-0531-0. Epub 2019 May 6. Genet Med. 2019. PMID: 31056551
-
Prematurity, ventricular septal defect and dysmorphisms are independent predictors of pathogenic copy number variants: a retrospective study on array-CGH results and phenotypical features of 293 children with neurodevelopmental disorders and/or multiple congenital anomalies.Ital J Pediatr. 2018 Mar 9;44(1):34. doi: 10.1186/s13052-018-0467-z. Ital J Pediatr. 2018. PMID: 29523172 Free PMC article.
-
Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders.Genet Med. 2019 Nov;21(11):2413-2421. doi: 10.1038/s41436-019-0554-6. Epub 2019 Jun 11. Genet Med. 2019. PMID: 31182824 Free PMC article.
-
Diagnostic genetic testing for neurodevelopmental psychiatric disorders: closing the gap between recommendation and clinical implementation.Curr Opin Genet Dev. 2021 Jun;68:1-8. doi: 10.1016/j.gde.2020.12.016. Epub 2021 Jan 9. Curr Opin Genet Dev. 2021. PMID: 33434711 Free PMC article. Review.
Cited by
-
[Genetic diagnostics of mental health disorders in adulthood].Nervenarzt. 2025 Jul;96(4):386-395. doi: 10.1007/s00115-024-01737-y. Epub 2024 Sep 24. Nervenarzt. 2025. PMID: 39316100 Free PMC article. Review. German.
References
-
- Canada Mental Health Commission. Making the case for investing in mental health. Mental Health Commission of Canada; 2013.
-
- Lim KL, Jacobs P, Ohinmaa A, Schopflocher D, Dewa C. A new population-based measure of the economic burden of mental illness in Canada. Chron Dis Canada. 2008;28(3):92–98. - PubMed
-
- Lunsky Y, Weiss J. Dual diagnosis: An information guide. Toronto (ON): Centre for Addiction and Mental Health; 2015.
-
- Buckley PF, Brown ES. Prevalence and consequences of dual diagnosis. J Clin Psychiatry. 2006;67(2):e01–e02. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical